These data suggest that ZY0511 specifically down-regulates BRCA1/2 and RAD51 in tumor cells but with no corresponding effect on these gene expression in non-malignant and healthy tissue (Supplementary Fig. 10e). Here, RAD51 is linked to neoplasm.